Drug Channels Institute — An HMP Global Company
Back to Industry Reports

Reports · March 2026

The 2026 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers

The most comprehensive, fact-based analysis of the evolving drug channels within the U.S. healthcare system — pharmacies, PBMs, patients’ costs, and the money that changes hands at each step.

The 2026 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers remains the most comprehensive, fact-based analysis of the evolving drug channels within the U.S. healthcare system.

This unique resource will benefit pharmaceutical manufacturers, wholesalers, pharmacists, pharmacy owners, hospital executives, buyers, benefit managers, managed care executives, policy analysts, investors, consultants—anyone who wants to understand and benefit from this ever-changing industry.

Use the sidebar to ask into specific chapters: distribution margins, PBM revenue, specialty mix, or how a launch is likely to be covered.

Ask about this article

Open a sidebar next to this piece — you stay on the article.